CAB Payments Holdings Limited a market lender to business to business (B2B) cross-border payments and foreign exchange, specialising in emerging markets intends to join the Premium Segment of the Main Market. The Group announced revenues of £41.3m for the three months ended 31 March 2023 with the YTD adjusted EBITDA margin at 64%. The Offer is expected to comprise a secondary sell-down of existing ordinary shares by Merlin Midco Limited (a wholly owned subsidiary of Helios Investors III, L.P. and Helios Investors III (A), L.P.) It is rumoured to be valued at between £800m and £1bn with Admission currently expected to occur in July 2023.
WE Soda, the world’s largest producer of natural soda ash, more commonly known in the UK as sodium carbonate or washing soda, announces that it is considering listing on the Premium Segment of the Main Market. WE Soda, an extractor of soda ash in Turkey and the US, is a subsidiary of Ciner Group, an industrial and media conglomerate. It is a high-margin business and last year it reported adjusted operating profits of $892m on revenues of $1.77 bn. The Offer would be wholly comprised of ordinary shares to be sold by the existing shareholder. Separately from and in addition to the Offer, the Company is also considering making an exempt public offer of Shares to retail. WE Soda has decided not to IPO in London stating “extreme investor caution” and “an inability to reach the valuation that it desired”. The Company was looking to raise up to $800m, valuing it at up to $7.5bn, with an offering to retail investors of up to £7m in shares.
Agronomics Limited 10.75p £106.8m (ANIC.L)
The company focused on the field of cellular agriculture, announce that it has invested AUD2.5m in HydGene Renewables Pty Ltd, a developer of synthetic biology to engineer microorganisms for use in hydrogen production. This investment was paid using cash from the Agronomics’ own resources and will result in Agronomics holding 188,239 Series Seed Preferred Shares and owning, on a fully diluted basis, 12.50% of HydGene. This is part of HydGene's AUD6m Seed financing round. Joining the round are the Clean Energy Finance Corporation (CEFC - whose investment is managed by Virescent Ventures), Understorey Ventures and NOAB Ventures.
Chaarat Gold Holdings 9.1p £62.8m (CGH.L)
The gold mining company with an operating mine in Armenia, and assets at various stages of development in the Kyrgyz Republic, announces its audited results for the 12 months ended 31 December 2022. Revenue amounted to US$92.3m (2021: US$92.4m). EBITDA was US$6.5m, 52% lower compared to last year (2021: US$13.5m). Cash and cash equivalents decreased from US$11.1m in 2021 to US$0.6m the end of 2022. To achieve the planned future capital developments of assets and to repay the convertible loan notes due on 31 July 2023, management will need to raise future financing. There are currently no binding agreements in place in respect of any additional funding.
Coro Energy 0.22p £6.1m (CORO.L)
The South East Asian energy company with a natural gas and clean energy portfolio, announces that it has signed the acquisition of a rooftop solar portfolio of 3.25MW from the shareholders of KIMY Trading and Service JSC (KIMY), as previously announced on 25 November 2022 and 29 March 2023. The total acquisition price is US$1.3m (US$543/MW) comprised of (1) at completion: assumption by Coro of US$600k of existing specialist renewables debt with a Vietnamese bank; US$112k payable in cash, of which US$30k is ring fenced to secure certain required firefighting certificates; US$285k payable in new ordinary shares in the Company to be issued at the mid- market price six months following completion and locked in for 18 months from completion; (2) A further US$300k in cash in six equal monthly instalments from completion. Completion of the acquisition of the Portfolio is expected to occur in Q4 2023.
Eden Research 8.6p £32.7m (EDEN.L)
The company focused on sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries, announces the appointment of Anasac Colombia Ltd (Anasac) as its exclusive distributor of Mevalone® in Colombia. Anasac's appointment precedes a regulatory application which will be made to the relevant authorities to allow the use of Mevalone on ornamental crops (such as freshly cut flowers) in Colombia to prevent and cure outbreaks of Botrytis cinerea. Once approved, ornamental plant growers and florists will be permitted to apply Mevalone to their flowers during production and after harvest.
GB Group 255.4p £644.9m (GBG.L)
The experts in digital location, identity verification and fraud prevention software, announces its audited results for the year ended 31 March 2023 (FY23). Statutory revenue grew 15.0% from £243m in FY22 to £279m in FY23 as a result of acquisitions and exceptional cryptocurrency volumes in the prior year. Operating loss was £112m (compared to operating profit of £23m in FY22), due to goodwill impairment charge of £122.2m against Identity business in the Americas (i.e., iDology and Acuant acquisitions). Net debt was £106m as at 31 March 2023 (FY22: £107m). The Board recommends a final dividend per ordinary share of 4.00p, up 5%. The Board is confident that GBG will deliver its FY24 profit expectations.
Horizonte Minerals 140.5p ££377.6m (HZM.L)
The nickel company developing two tier 1 assets in Brazil, presents the second pictorial update showing construction progress at the Company's Araguaia Nickel Project. Horizonte Minerals is developing two 100%-owned, Tier 1 projects in Pará state, Brazil, the Araguaia Nickel Project and the Vermelho Nickel-Cobalt Project. Both projects are large scale, high-grade, low-cost, low-carbon and scalable. Araguaia is under construction with first metal scheduled for early 2024. When fully ramped up, with Line 1 and Line 2, it is forecast to produce 29k tonnes of nickel per year. Vermelho is at feasibility study stage and is expected to produce 24k tonnes of nickel and 1.25k tonnes of cobalt to supply the EV battery market.
N Brown Group 23.9p £108.9m (BWNG.L)
The top 10 UK clothing & footwear digital retailer, provides a trading update for the 13 weeks ended 3 June 2023 (Q1 FY24). Group revenue was £148.7m (down 9% year-on-year), comprised of £93.6m product revenue (down 11.9% year-on-year) and £55.1m financial service revenue (down 6.3% year-on-year). Trading was in line with the Board's expectations. Strong balance sheet maintained, with total accessible liquidity of c. £118m. The Group continued investment in transformational priorities including moving towards full roll-out of new mobile-first website for Jacamo, following successful launch of new Simply Be website. FY24 guidance remains unchanged.
Oriole Resources 0.20p £5.6m (ORR.L)
The exploration company focussed on West Africa, provides an exploration update on its 90%-owned Bibemi orogenic gold project in Cameroon. In December 2022, the Company reported a maiden JORC-compliant Resource of 305kTroy ounces grading 2.19 grammes per tonne (g/t) gold (Au) for Bakassi Zone 1, one of four prospects at the Project. An additional JORC Exploration Target at Bakassi Zone 1 is estimated to be between 1.5-2.2m tonnes at grades ranging from 1.10 to 2.10 g/t for between an additional 53k and 148k oz of Au. There exists significant potential to expand the Resource at Bakassi Zone 1 and to identify additional resources at the other three prospects on the licence, Bakassi Zone 2, Lawa West and Lawa East, which are all located within a few kilometres of Bakassi Zone 1.
Parkmead Group 18.5p £20.2m (PMG.L)
The last 18 months has seen Parkmead deliver strong cash flow from natural gas fields in the Netherlands, plus income from renewable energy for the first time with sales of electricity direct to the national grid from Parkmead's wind turbines in the UK. As a result, Parkmead announces the appointment of Andrew Smith MRICS to the Board of directors, effect from 15 June 2023. Andrew is Parkmead's existing Managing Director of Renewables. In addition, Group Financial Controller Ryan Stroulger's employment with the Company has ended by mutual agreement.
Warpaint London 282.5p £216.8m (W7L.L)
The specialist supplier of colour cosmetics and owner of the W7 and Technic brands, provides a trading update. Strong trading has continued in Q2 2023. Sales for the five months to 31 May 2023 were £29.7m, 45% ahead of the same period last year with margins continuing to be robust and ahead of those achieved in 2022. The Board now expects that the Group's full year 2023 performance will be ahead of its prior expectations. Cash balances as at 31 May 2023 was £7.5m (31 December 2022: £5.8m) and no debt.
Disclaimer
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@chrish351.sg-host.com with “unsubscribe me”.
